Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-phase Prednisolone before R-CHOP in Elderly DLBCL
NCT03465527Phase 2Completed
- Start
- Apr 2017
- Primary completion
- Jul 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label trial of prednisolone in diffuse large B-cell lymphoma (DLBCL). Primary endpoint: Treatment-Related Mortality Rate at 1 year. Started Apr 2017; status: completed.
02
Drugs
prednisolone
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT03465527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03465527.